We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

42 hedge funds and large institutions have $25.7M invested in AYTU BioPharma in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 1 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 1

84% more capital invested

Capital invested by funds: $14M → $25.7M (+$11.8M)

1.2% more ownership

Funds ownership: 0.05% → 1.25% (+1.2%)

26% less funds holding

Funds holding: 57 → 42 (-15)

54% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 26

Holders
42
Holders Change
-15
Holders Change %
-26.32%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
19
Reduced
1
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$12.7M
2
AC
Armistice Capital
New York
+$12.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.08M
4
Citadel Advisors
Citadel Advisors
Florida
+$752K
5
PSC
Piper Sandler & Co
Minnesota
+$452K

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$118K
2
AllianceBernstein
AllianceBernstein
Tennessee
-$109K
3
Jane Street
Jane Street
New York
-$68K
4
VCA
Verdence Capital Advisors
Maryland
-$67K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
51
Sigma Planning Corp
Michigan
– -$28K -116 Closed
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
– -$25K -105 Closed
TSS
53
Two Sigma Securities
New York
– -$24K -101 Closed
TCM
54
Traynor Capital Management
Pennsylvania
– -$19K -100 Closed
HighTower Advisors
55
HighTower Advisors
Illinois
– -$22K -95 Closed
GSIS
56
Global Strategic Investment Solutions
Arizona
– -$22K -93 Closed
Victory Capital Management
57
Victory Capital Management
Texas
– -$20K -85 Closed
JIP
58
Jaffetilchin Investment Partners
Florida
– -$17K -72 Closed
Cambridge Investment Research Advisors
59
Cambridge Investment Research Advisors
Iowa
– -$17K -70 Closed
PFS
60
Prospera Financial Services
Texas
– -$14K -57 Closed
Barclays
61
Barclays
United Kingdom
– -$12K -53 Closed
TCA
62
Transcend Capital Advisors
New Jersey
– -$12K -50 Closed
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
– -$8.34K -35 Closed
IA
64
IFP Advisors
Florida
– -$2.73K -15 Closed
APA
65
American Portfolios Advisors
New York
– -$2.38K -10 Closed
QCG
66
Quadrant Capital Group
Ohio
– +$546 +3 New
1 2
3

AYTU Hedge Fund Activity: Q4 2020 in Review

42 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2020, worth a combined $25.7M — up 84% from $14M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AYTU and 12 opened new positions — a net loss of 14 holders — while 1 trimmed existing stakes and 19 added.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $12.7M. The largest seller was Nuveen, exiting entirely with an estimated $118K sold.

  • 42 institutional investors held AYTU BioPharma (AYTU) as of Q4 2020, down from 57 in Q3 2020.
  • Funds reported $25.7M of AYTU BioPharma stock for Q4 2020, up 84% quarter-over-quarter.
  • 12 funds opened new AYTU BioPharma positions in Q4 2020 and 26 closed out, a net change of -14 holders.
  • The largest AYTU BioPharma buyer in Q4 2020 was Stonepine Capital Management, an estimated $12.7M added.
  • The largest AYTU BioPharma seller in Q4 2020 was Nuveen, an estimated $118K sold.

Based on aggregated 13F filings for Q4 2020.